Perinatal Outcome in Maternal COVID-19 infection at a Tertiary care Institute- A cross Sectional Study

ABSTRACT: COVID 19 pandemic is one of the biggest challenge to health system of developing as well as developed countries. Because of the novelty of the virus, limited data were available regarding perinatal outcome. The objective of this study is to find out the perinatal outcome in COVID-19 infected mothers who delivered during COVID Pandemic. METHODOLOGY: A cross sectional study was carried out at PCMC’S Post-Graduate Institute and YCM Hospital Pune (Maharashtra) from 1 May 2020 to 31 October 2021 which was a dedicated COVID hospital during COVID pandemic. A total of 362 maternity patients (including 5 twin pregnancies) having COVID 19 infection who gave birth to 367 Newborns were studied. Maternal COVID -19 infection was diagnosed either by RTPCR test or Rapid Antigen test. Demographic variables, maternal symptoms, labour and neonatal outcome were recorded. RT PCR of neonates at birth was performed. Data was analyzed statistically by using Epi Info Software. AIM: To analyze the perinatal outcome among COVID-19 infected mothers who delivered during Covid pandemic. OBJECTIVES: Study was conducted with the primary objective to analyze the labour outcome, maternal symptoms and secondarily to study maternal demographic profile and to compare disease severity during 1(st) and 2(nd) wave of COVID and to detect possibility of vertical transmission of COVID-19 in neonates of covid positive mothers. RESULTS: 74.2% patients from young reproductive age (21–30 years age) were affected. All socioeconomic classes were affected. 61% patients were multigravida. Normal BMI was noted in 49.8%. 28.2% deliveries were preterm. Caesarean section rate was 50.5%. Following obstetric high risk factors were noted—anaemia in 34.2% followed by previous LSCS in 26.2% cases and preeclampsia in 18.7% Overall 54.6% patients were asymptomatic while 45.4% were symptomatic. Symptomatology between 1(st) and 2(nd) wave showed statistical significance (p value < .05%) for mild, moderate and severe symptoms. Myalgia, cough, fever and fatigue were common presenting symptoms. 14% patients required ICU/HDU care. HDU/ICU requirement showed statistical significance (p value < .05) between 1(st) and 2(nd) wave. Overall maternal mortality was 1.1% (4 maternal deaths in 2(nd) wave) with no mortality in 1(st) wave. 96.4% were live births. Birth weight was more than 2.5 kg in 62% cases and 21.3% cases required NICU. Vertical transmission of COVID was seen in 1.1% cases. CONCLUSION: Pregnant patients with moderate and severe disease are at higher risk of perinatal complications. ICU/HDU management with multidisciplinary management may reduce morbidity and mortality. Neonatal affection due to COVID may not be severe but may increase prematurity due to iatrogenic intervention.